Royal Bank of Canada
NWBO

Royal Bank of Canada’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Royal Bank of Canada’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-19
Closed – – 7040
2016
Q3 		$0 Sell
19
-3,750
-99% -$1.72K ﹤0.01% 6889
2016
Q2 		$2K Buy
+3,769
New +$4.02K ﹤0.01% 6204
2016
Q1 		– Sell
-61
Closed – – 7130
2015
Q4 		$0 Sell
61
-1,988
-97% -$9.56K ﹤0.01% 7270
2015
Q3 		$13K Sell
2,049
-412
-17% -$3.85K ﹤0.01% 5794
2015
Q2 		$24K Buy
+2,461
New +$21.6K ﹤0.01% 5624
2015
Q1 		– Sell
-509,614
Closed -$2.73M – 6797
2014
Q4 		$2.73M Sell
509,614
-4,100
-0.8% -$21K ﹤0.01% 2092
2014
Q3 		$2.58M Sell
513,714
-2,150
-0.4% -$13.2K ﹤0.01% 2104
2014
Q2 		$3.46M Sell
515,864
-2,702
-0.5% -$17.2K ﹤0.01% 1899
2014
Q1 		$3.75M Buy
518,566
+335
+0.1% +$1.99K ﹤0.01% 1795
2013
Q4 		$1.95M Buy
518,231
+110,073
+27% +$426K ﹤0.01% 2320
2013
Q3 		$1.37M Buy
+408,158
New +$1.42M ﹤0.01% 2488

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Royal Bank of Canada's NWBO Position: Q4 2016 in Review

Royal Bank of Canada sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 19 shares.

Royal Bank of Canada first reported a position in NWBO in Q3 2013 and held it in 11 quarters. The position peaked at $3.75M in Q1 2014. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Royal Bank of Canada reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • Royal Bank of Canada sold 19 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016.
  • Royal Bank of Canada first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q3 2013 and held it in 11 quarters.
  • Royal Bank of Canada's Northwest Biotherapeutics, Inc. Common stock position peaked at $3.75M in Q1 2014.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Royal Bank of Canada's 13F filing for Q4 2016, filed 14 Feb 2017.